{"recordsFiltered":48720,"recordsTotal":48720,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&start=37800","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&start=37200","results":[{"registry_id":"NCT06741397","publication_url":"https://clinicaltrials.gov/study/NCT06741397","title":"A Phase 2b Single Arm, Repeat Dose Study to Evaluate the Pharmacokinetic Profile, Safety, and Tolerability of A New Formulation of Cabotegravir LA Injected Intramuscularly Q4M in Adolescent and Adult Participants at Risk of HIV Acquisition","has_exemption":false,"start_date":"2024-12-20","completion_date":"2026-09-09","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04435834","publication_url":"https://clinicaltrials.gov/study/NCT04435834","title":"Cerebral Hemodynamics- ICHOR II","has_exemption":false,"start_date":"2020-06-09","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Matthew Borzage","sponsor_slug":"matthew-borzage","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05523505","publication_url":"https://clinicaltrials.gov/study/NCT05523505","title":"Bridging the Gap Between Brain Network Science and High-definition Non-invasive Brain Stimulation to Develop a Scalable Adult Literacy Intervention","has_exemption":false,"start_date":"2022-11-07","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University","sponsor_slug":"vanderbilt-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672173","publication_url":"https://clinicaltrials.gov/study/NCT05672173","title":"Phase 2 Study of the Combination of Lisocabtagene Maraleucel, Nivolumab, and Ibrutinib in Richter's Transformation","has_exemption":false,"start_date":"2023-06-02","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05660980","publication_url":"https://clinicaltrials.gov/study/NCT05660980","title":"Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age","has_exemption":false,"start_date":"2024-01-24","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05831202","publication_url":"https://clinicaltrials.gov/study/NCT05831202","title":"SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial","has_exemption":false,"start_date":"2024-08-06","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Galaxy Therapeutics INC","sponsor_slug":"galaxy-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855160","publication_url":"https://clinicaltrials.gov/study/NCT06855160","title":"A Phase 3a, Open-Label, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Varicella Vaccine and Priorix Compared With Subcutaneous Administration of Varivax and Priorix, When Given as a First Dose to Healthy Children 12 to 15 Months of Age","has_exemption":false,"start_date":"2025-04-17","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301385","publication_url":"https://clinicaltrials.gov/study/NCT07301385","title":"Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Feasibility and Safety Study","has_exemption":false,"start_date":"2026-03-11","completion_date":"2026-09-10","has_results":false,"results_due":false,"sponsor_name":"Sharp HealthCare","sponsor_slug":"sharp-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03198026","publication_url":"https://clinicaltrials.gov/study/NCT03198026","title":"Phase II, Single Arm, Open Label Multi-center Study of Obinutuzumab and Ibrutinib in the Front Line Treatment of Indolent Non-Hodgkin's Lymphomas","has_exemption":false,"start_date":"2018-02-20","completion_date":"2026-09-11","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996003","publication_url":"https://clinicaltrials.gov/study/NCT05996003","title":"A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089/NCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)","has_exemption":false,"start_date":"2024-02-22","completion_date":"2026-09-11","has_results":false,"results_due":false,"sponsor_name":"NS Pharma, Inc.","sponsor_slug":"ns-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06431373","publication_url":"https://clinicaltrials.gov/study/NCT06431373","title":"A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis","has_exemption":false,"start_date":"2024-09-11","completion_date":"2026-09-11","has_results":false,"results_due":false,"sponsor_name":"Priovant Therapeutics, Inc.","sponsor_slug":"priovant-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03417388","publication_url":"https://clinicaltrials.gov/study/NCT03417388","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","has_exemption":false,"start_date":"2018-02-09","completion_date":"2026-09-14","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04634877","publication_url":"https://clinicaltrials.gov/study/NCT04634877","title":"A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)","has_exemption":false,"start_date":"2021-01-10","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05800366","publication_url":"https://clinicaltrials.gov/study/NCT05800366","title":"A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2023-04-06","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Jennifer Crombie, MD","sponsor_slug":"jennifer-crombie-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06471829","publication_url":"https://clinicaltrials.gov/study/NCT06471829","title":"A Phase II, Multi-site, Open-label, Dose-titration Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Lu AG13909 in Adults With Cushing's Disease","has_exemption":false,"start_date":"2024-06-19","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449378","publication_url":"https://clinicaltrials.gov/study/NCT06449378","title":"Multi-center, Single-arm, Prospective Study of Transorb™ Self-Gripping REsorbable Mesh in High-risk subjeCts Undergoing Open Repair of VEntral heRnia","has_exemption":false,"start_date":"2024-07-02","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053255","publication_url":"https://clinicaltrials.gov/study/NCT06053255","title":"Safety and Efficacy of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis","has_exemption":false,"start_date":"2024-09-13","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"FUSMobile Inc.","sponsor_slug":"fusmobile-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113211","publication_url":"https://clinicaltrials.gov/study/NCT06113211","title":"Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665971","publication_url":"https://clinicaltrials.gov/study/NCT06665971","title":"Effect of Dupilumab on Esophageal Peristaltic Function in Participants with Eosinophilic Esophagitis","has_exemption":false,"start_date":"2024-11-10","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06689254","publication_url":"https://clinicaltrials.gov/study/NCT06689254","title":"REVERSE: a Randomized Controlled Trial (RCT) to Ameliorate Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism","has_exemption":false,"start_date":"2024-11-15","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Christiaan Vinkers","sponsor_slug":"christiaan-vinkers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06807463","publication_url":"https://clinicaltrials.gov/study/NCT06807463","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease While Undergoing Oral Gluten Exposure","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Teva Branded Pharmaceutical Products R&D LLC","sponsor_slug":"teva-branded-pharmaceutical-products-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07151729","publication_url":"https://clinicaltrials.gov/study/NCT07151729","title":"Use of Anodal Transcranial Direct Current Stimulation to Enhance Upper Limb Recovery in Stroke","has_exemption":false,"start_date":"2025-09-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Tan Tock Seng Hospital","sponsor_slug":"tan-tock-seng-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214415","publication_url":"https://clinicaltrials.gov/study/NCT07214415","title":"Evaluating the Effects of Hyperbaric Oxygen Therapy on Cognitive Function, Mental Health, and Quality of Life in Veterans","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Summit Hyperbarics and Wellness","sponsor_slug":"summit-hyperbarics-and-wellness","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06632379","publication_url":"https://clinicaltrials.gov/study/NCT06632379","title":"AtorvaStatin Postpartum and Reduction of Cardiovascular risK (SPARK): A Randomized Placebo-controlled Trial of Atorvastatin Postpartum for Reduction of Cardiovascular Risk","has_exemption":false,"start_date":"2025-10-03","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07318792","publication_url":"https://clinicaltrials.gov/study/NCT07318792","title":"Evaluation of the Safety and the Clinical Effectiveness of Using Tropocells® Autologous PRF System to Treat Chronic, Non-healing, Non-infected Wounds in Combination With Standard of Care (SOC).","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Estar Medical dba Medical Technologies, LTD","sponsor_slug":"estar-medical-dba-medical-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517237","publication_url":"https://clinicaltrials.gov/study/NCT07517237","title":"Combining At-Home Transcutaneous Auricular Vagus Nerve Stimulation and Computerized Cognitive Training for Neurocognitive Rehabilitation","has_exemption":false,"start_date":"2026-03-12","completion_date":"2026-09-15","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04353778","publication_url":"https://clinicaltrials.gov/study/NCT04353778","title":"Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV","has_exemption":false,"start_date":"2020-08-03","completion_date":"2026-09-16","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05910619","publication_url":"https://clinicaltrials.gov/study/NCT05910619","title":"Transcranial Pulse Stimulation of the Brain in Older Adults With and Without Mild Dementia","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-09-16","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06832410","publication_url":"https://clinicaltrials.gov/study/NCT06832410","title":"A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-09-17","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213154","publication_url":"https://clinicaltrials.gov/study/NCT07213154","title":"Assessment of Novel Label-free Optical Imaging Technology for the Evaluation of Skin Lesions","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-09-17","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226375","publication_url":"https://clinicaltrials.gov/study/NCT07226375","title":"Comparison of Endoscopic Tissue Cutting and Abdominal Extraction Device With Conventional Cold Scalpel","has_exemption":false,"start_date":"2025-11-13","completion_date":"2026-09-17","has_results":false,"results_due":false,"sponsor_name":"Ege University","sponsor_slug":"ege-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03162536","publication_url":"https://clinicaltrials.gov/study/NCT03162536","title":"A Phase 1/2 Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ARQ 531 in Selected Subjects With Relapsed or Refractory Hematologic Malignancies","has_exemption":false,"start_date":"2017-06-26","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)","sponsor_slug":"arqule-inc-a-subsidiary-of-merck-sharp-dohme-llc-a-subsidiary-of-merck-co-inc-rahway-nj-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04237623","publication_url":"https://clinicaltrials.gov/study/NCT04237623","title":"Phase II Trial Evaluating the Efficacy and Safety of Sargramostim Post-Infusion of T-Replete HLA Mismatched Peripheral Blood Haploidentical Hematopoietic Stem Cells and With Post Transplant Cyclophosphamide","has_exemption":false,"start_date":"2020-05-18","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Northside Hospital, Inc.","sponsor_slug":"northside-hospital-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03843463","publication_url":"https://clinicaltrials.gov/study/NCT03843463","title":"Escitalopram and Language Intervention for Subacute Aphasia (ELISA)","has_exemption":false,"start_date":"2021-07-18","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233461","publication_url":"https://clinicaltrials.gov/study/NCT06233461","title":"A Phase 2b, Multicenter, Randomized, Double-Blind Induction, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2024-03-05","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07145333","publication_url":"https://clinicaltrials.gov/study/NCT07145333","title":"Explore the Relationship Between Single Nucleotide Polymorphisms and Topotecan Response and Toxicity in Patients With Small Cell Lung Cancer.","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-09-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145373","publication_url":"https://clinicaltrials.gov/study/NCT06145373","title":"An Open-label, Single-arm Treatment Study to Investigate the Safety and Tolerability of Switching From Emicizumab to Fitusiran Prophylaxis in Male Participants Aged ≥12 Years of Age With Severe Hemophilia A, With or Without Inhibitors","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-09-19","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05593237","publication_url":"https://clinicaltrials.gov/study/NCT05593237","title":"A Pilot Trial of Longitudinal Repetitive Transcranial Magnetic Stimulation (rTMS) for Chronic Neuropathic Pain","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-09-20","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05240014","publication_url":"https://clinicaltrials.gov/study/NCT05240014","title":"Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Orthoses","has_exemption":false,"start_date":"2022-07-29","completion_date":"2026-09-20","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03312556","publication_url":"https://clinicaltrials.gov/study/NCT03312556","title":"Treatment of Supine Hypertension in Autonomic Failure With Continuous Positive Airway Pressure","has_exemption":false,"start_date":"2017-09-21","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06719739","publication_url":"https://clinicaltrials.gov/study/NCT06719739","title":"Clinical Outcomes in Cataract Patients With Macular Epiretinal Membrane After Implantation of Functional Intraocular Lenses","has_exemption":false,"start_date":"2024-09-21","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Eye & ENT Hospital of Fudan University","sponsor_slug":"eye-ent-hospital-of-fudan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06643481","publication_url":"https://clinicaltrials.gov/study/NCT06643481","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Parallel Group Study of VHB937 in Amyotrophic Lateral Sclerosis (ALS) Over 40 Weeks Followed by an Open Label Extension (ASTRALS)","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06708299","publication_url":"https://clinicaltrials.gov/study/NCT06708299","title":"CardiolRxTM in Recurrent Pericarditis (MAVERIC Phase 3) A Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-09-21","has_results":false,"results_due":false,"sponsor_name":"Cardiol Therapeutics Inc.","sponsor_slug":"cardiol-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01909245","publication_url":"https://clinicaltrials.gov/study/NCT01909245","title":"Islet Transplantation Using a T-Cell Depleting Immunosuppression Induction Regimen","has_exemption":false,"start_date":"2013-10-16","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04370587","publication_url":"https://clinicaltrials.gov/study/NCT04370587","title":"A Phase 1/2a, Open-Label, Dose Escalation and Expansion Study of the Safety and Tolerability of T3011 Administered Via Intratumoral Injection as a Single Agent and in Combination With Intravenous Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-09-17","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"ImmVira Pharma Co. Ltd","sponsor_slug":"immvira-pharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05992935","publication_url":"https://clinicaltrials.gov/study/NCT05992935","title":"A Phase 1/2, Randomized, Placebo-Controlled, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405, Multivalent Candidate Vaccines to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","has_exemption":false,"start_date":"2023-08-25","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05952037","publication_url":"https://clinicaltrials.gov/study/NCT05952037","title":"An Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of the BCL2 Inhibitor Sonrotoclax (BGB-11417) as Monotherapy and in Combination With Zanubrutinib (BGB-3111) in Patients With Waldenström Macroglobulinemia","has_exemption":false,"start_date":"2023-10-23","completion_date":"2026-09-22","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04557449","publication_url":"https://clinicaltrials.gov/study/NCT04557449","title":"A PHASE 1/2A STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF PF-07220060 AS A SINGLE AGENT AND AS PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS","has_exemption":false,"start_date":"2020-09-23","completion_date":"2026-09-23","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883437","publication_url":"https://clinicaltrials.gov/study/NCT04883437","title":"An Open-Label Phase 2 Trial of Acalabrutinib Plus Obinutuzumab in Patients With Untreated, Low Tumor Burden Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2021-09-03","completion_date":"2026-09-23","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05296512","publication_url":"https://clinicaltrials.gov/study/NCT05296512","title":"A Phase II Trial of Pembrolizumab and Lenvatinib in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary","has_exemption":false,"start_date":"2022-09-23","completion_date":"2026-09-23","has_results":false,"results_due":false,"sponsor_name":"Elizabeth K. Lee MD","sponsor_slug":"elizabeth-k-lee-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05380921","publication_url":"https://clinicaltrials.gov/study/NCT05380921","title":"Testing a Novel Dry Electrode Headset for Electroencephalography Telehealth","has_exemption":false,"start_date":"2022-10-01","completion_date":"2026-09-25","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281963","publication_url":"https://clinicaltrials.gov/study/NCT07281963","title":"Chilipad Sleep Optimization Study","has_exemption":false,"start_date":"2025-09-25","completion_date":"2026-09-25","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298369","publication_url":"https://clinicaltrials.gov/study/NCT07298369","title":"Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)","has_exemption":false,"start_date":"2025-09-25","completion_date":"2026-09-25","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04083963","publication_url":"https://clinicaltrials.gov/study/NCT04083963","title":"BRE-01: Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel Followed by Doxorubicin and Cyclophosphamide in Triple Negative Breast Cancer","has_exemption":false,"start_date":"2019-08-09","completion_date":"2026-09-27","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04961567","publication_url":"https://clinicaltrials.gov/study/NCT04961567","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care","has_exemption":false,"start_date":"2021-07-16","completion_date":"2026-09-27","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066333","publication_url":"https://clinicaltrials.gov/study/NCT06066333","title":"Safety and Immunological Effects of Pembrolizumab Plus Ablative Radiotherapy in Patients With Advanced Adrenocortical Carcinoma","has_exemption":false,"start_date":"2023-09-27","completion_date":"2026-09-27","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02194738","publication_url":"https://clinicaltrials.gov/study/NCT02194738","title":"Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)","has_exemption":false,"start_date":"2014-09-26","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05206942","publication_url":"https://clinicaltrials.gov/study/NCT05206942","title":"Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy","has_exemption":false,"start_date":"2022-03-21","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05336695","publication_url":"https://clinicaltrials.gov/study/NCT05336695","title":"Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET","has_exemption":false,"start_date":"2022-03-29","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05956626","publication_url":"https://clinicaltrials.gov/study/NCT05956626","title":"A PHASE 1 STUDY TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE AND PHASE 2/3 PIVOTAL CONFIRMATORY CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE","has_exemption":false,"start_date":"2023-08-25","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Ocugen","sponsor_slug":"ocugen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05951049","publication_url":"https://clinicaltrials.gov/study/NCT05951049","title":"A Phase 2, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of AT-02","has_exemption":false,"start_date":"2023-09-21","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Attralus, Inc.","sponsor_slug":"attralus-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05705024","publication_url":"https://clinicaltrials.gov/study/NCT05705024","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05888844","publication_url":"https://clinicaltrials.gov/study/NCT05888844","title":"A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Squamous Cell Carcinoma","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06768671","publication_url":"https://clinicaltrials.gov/study/NCT06768671","title":"An Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents Aged ≥12 to ≤17 Years at the Time of Study Inclusion With Active Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2024-12-30","completion_date":"2026-09-28","has_results":false,"results_due":false,"sponsor_name":"MoonLake Immunotherapeutics AG","sponsor_slug":"moonlake-immunotherapeutics-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04577014","publication_url":"https://clinicaltrials.gov/study/NCT04577014","title":"A Multi-cohort Study of Retifanlimab With or Without Gemcitabine and Docetaxel in Patients With Advanced Sarcoma","has_exemption":false,"start_date":"2020-09-29","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05263934","publication_url":"https://clinicaltrials.gov/study/NCT05263934","title":"A 52-week, Randomized, Double-blind, Double-dummy, Parallel-group, Multi-centre, Non-inferiority Study to Investigate the Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Receiving Standard of Care (SoC) Therapy","has_exemption":false,"start_date":"2022-07-14","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05392946","publication_url":"https://clinicaltrials.gov/study/NCT05392946","title":"Phase 1/2 Trial of Iberdomide in Combination With Daratumumab, BortEzomib and DexamethAsone in Patients With Newly Diagnosed Multiple MyeLoma (IDEAL)","has_exemption":false,"start_date":"2022-08-11","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04217603","publication_url":"https://clinicaltrials.gov/study/NCT04217603","title":"Effect of Continuous Positive Airway Pressure (CPAP) on 6-Minute Walk Test Outcomes in Patients With Excessive Central Airway Collapse (ECAC)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943404","publication_url":"https://clinicaltrials.gov/study/NCT06943404","title":"Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With a Sublingual Formulation of Dexmedetomidine (BXCL501)","has_exemption":false,"start_date":"2026-02-23","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07555483","publication_url":"https://clinicaltrials.gov/study/NCT07555483","title":"An Open-Label, Multicenter, Randomized, Non-Inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Weekly Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Patients With Alpha1-Antitrypsin Deficiency Compared to Corresponding Standard 60 mg/kg/Week and 120 mg/kg/Week Doses of Intravenous Alpha1-Proteinase Inhibitor (5%)","has_exemption":false,"start_date":"2026-04-21","completion_date":"2026-09-29","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00179465","publication_url":"https://clinicaltrials.gov/study/NCT00179465","title":"Addition of Tiagabine to Second-Generation Antipsychotics in the Treatment of Recent-Onset Schizophrenia by Modification of Developmental Reorganization of the Prefrontal Cortex","has_exemption":false,"start_date":"2003-11-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00525720","publication_url":"https://clinicaltrials.gov/study/NCT00525720","title":"Transperineal Interstitial Permanent Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma","has_exemption":false,"start_date":"2006-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00734877","publication_url":"https://clinicaltrials.gov/study/NCT00734877","title":"UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)","has_exemption":false,"start_date":"2008-07-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01203839","publication_url":"https://clinicaltrials.gov/study/NCT01203839","title":"A Phase II Study of Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer","has_exemption":false,"start_date":"2010-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01410942","publication_url":"https://clinicaltrials.gov/study/NCT01410942","title":"Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy","has_exemption":false,"start_date":"2012-02-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01688492","publication_url":"https://clinicaltrials.gov/study/NCT01688492","title":"A Phase 2 Study Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer","has_exemption":false,"start_date":"2012-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01709292","publication_url":"https://clinicaltrials.gov/study/NCT01709292","title":"Pharmacodynamic Study of Vemurafenib in the Neoadjuvant Setting in Patients With Locally Advanced Thyroid Cancer","has_exemption":false,"start_date":"2012-11-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01815359","publication_url":"https://clinicaltrials.gov/study/NCT01815359","title":"ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multi-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis","has_exemption":false,"start_date":"2013-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02138734","publication_url":"https://clinicaltrials.gov/study/NCT02138734","title":"A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2014-07-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02176967","publication_url":"https://clinicaltrials.gov/study/NCT02176967","title":"Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma","has_exemption":false,"start_date":"2014-08-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02131584","publication_url":"https://clinicaltrials.gov/study/NCT02131584","title":"Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL): A Phase II Study","has_exemption":false,"start_date":"2014-09-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05708911","publication_url":"https://clinicaltrials.gov/study/NCT05708911","title":"Impact of External Pharyngeal Exerciser on Pharyngeal Phase of Swallowing","has_exemption":false,"start_date":"2014-09-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02444741","publication_url":"https://clinicaltrials.gov/study/NCT02444741","title":"Phase I/II Trial of MK-3475 and Hypofractionated Stereotactic Radiation Therapy in Patients With NSCLC","has_exemption":false,"start_date":"2015-09-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02397083","publication_url":"https://clinicaltrials.gov/study/NCT02397083","title":"Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer","has_exemption":false,"start_date":"2015-09-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02736656","publication_url":"https://clinicaltrials.gov/study/NCT02736656","title":"Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of SPN-812 for the Treatment of Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)","has_exemption":false,"start_date":"2016-02-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Supernus Pharmaceuticals, Inc.","sponsor_slug":"supernus-pharmaceuticals-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02849223","publication_url":"https://clinicaltrials.gov/study/NCT02849223","title":"Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury","has_exemption":false,"start_date":"2016-07-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Minneapolis Veterans Affairs Medical Center","sponsor_slug":"minneapolis-veterans-affairs-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02847559","publication_url":"https://clinicaltrials.gov/study/NCT02847559","title":"A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma","has_exemption":false,"start_date":"2016-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02932150","publication_url":"https://clinicaltrials.gov/study/NCT02932150","title":"A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects With Chronic Hepatitis B Virus Infection","has_exemption":false,"start_date":"2016-11-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02914535","publication_url":"https://clinicaltrials.gov/study/NCT02914535","title":"A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis","has_exemption":false,"start_date":"2017-02-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Alfasigma S.p.A.","sponsor_slug":"alfasigma-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03094429","publication_url":"https://clinicaltrials.gov/study/NCT03094429","title":"An Adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®,a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults","has_exemption":false,"start_date":"2017-03-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"SyneuRx International (Taiwan) Corp","sponsor_slug":"syneurx-international-taiwan-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03117751","publication_url":"https://clinicaltrials.gov/study/NCT03117751","title":"Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","has_exemption":false,"start_date":"2017-03-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03125642","publication_url":"https://clinicaltrials.gov/study/NCT03125642","title":"Autologous Stem Cell Transplant In Patients With Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphomas (NHL)","has_exemption":false,"start_date":"2017-04-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03282344","publication_url":"https://clinicaltrials.gov/study/NCT03282344","title":"A Pilot Study of NKTR-214 and Nivolumab in Selected Patients With Locally Advanced/Metastatic Sarcoma (CA209-9EM)","has_exemption":false,"start_date":"2017-09-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05370287","publication_url":"https://clinicaltrials.gov/study/NCT05370287","title":"Adaptive Optics Retinal Imaging","has_exemption":false,"start_date":"2018-01-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Food and Drug Administration (FDA)","sponsor_slug":"food-and-drug-administration-fda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03392324","publication_url":"https://clinicaltrials.gov/study/NCT03392324","title":"Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Atrophic Dry Age Related Macular Degeneration","has_exemption":false,"start_date":"2018-04-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Science Corporation","sponsor_slug":"science-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03571568","publication_url":"https://clinicaltrials.gov/study/NCT03571568","title":"Phase 1/2a Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma That Has Relapsed or is Refractory to Rituximab","has_exemption":false,"start_date":"2018-05-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03544632","publication_url":"https://clinicaltrials.gov/study/NCT03544632","title":"A Phase II, Dose-escalation, Open-label Study Evaluating the Safety and Efficacy of Permanently-placed Acellular Adipose Tissue (AAT) in Human Subjects With Modest Soft Tissue Defects of the Trunk","has_exemption":false,"start_date":"2018-06-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03582124","publication_url":"https://clinicaltrials.gov/study/NCT03582124","title":"A Phase I/II Study Evaluating the Safety and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Lung Cancer During Surgical Procedures","has_exemption":false,"start_date":"2018-07-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03286868","publication_url":"https://clinicaltrials.gov/study/NCT03286868","title":"Balancing Kinematically Aligned Total Knee Replacements During Total Primary Knee Arthroplasty Using Verasense","has_exemption":false,"start_date":"2018-07-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03573648","publication_url":"https://clinicaltrials.gov/study/NCT03573648","title":"A Pilot Study of IMMUNe mOdulation in Early Stage Estrogen Receptor Positive Breast Cancer Treated With neoADjuvant Avelumab, Palbociclib, and Endocrine Therapy: The ImmunoADAPT Study","has_exemption":false,"start_date":"2018-11-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03823144","publication_url":"https://clinicaltrials.gov/study/NCT03823144","title":"Intravital Microscopy (IVM) in Human Solid Tumors","has_exemption":false,"start_date":"2019-02-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03401398","publication_url":"https://clinicaltrials.gov/study/NCT03401398","title":"Stress Hydrocortisone In Pediatric Septic Shock","has_exemption":false,"start_date":"2019-03-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Jerry Zimmerman","sponsor_slug":"jerry-zimmerman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03104517","publication_url":"https://clinicaltrials.gov/study/NCT03104517","title":"CELLEBRATE: A Double-Blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Persistent or Recurrent Stress Urinary Incontinence Following Surgical Treatment","has_exemption":false,"start_date":"2019-04-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Cook MyoSite","sponsor_slug":"cook-myosite","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03740204","publication_url":"https://clinicaltrials.gov/study/NCT03740204","title":"The Role of Estrogen in the Neurobiology of Eating Disorders: A Study of Cognitive Flexibility and Reward in Eating Disorders","has_exemption":false,"start_date":"2019-06-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03492671","publication_url":"https://clinicaltrials.gov/study/NCT03492671","title":"A Phase II Trial of Pre-operative Chemotherapy (With Gemcitabine and Nab- Paclitaxel) and Stereotactic Body Radiotherapy Followed by Surgery and Chemotherapy in Patients With Resectable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2019-07-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04074356","publication_url":"https://clinicaltrials.gov/study/NCT04074356","title":"Non-invasive Markers of Esophageal Function in Adults","has_exemption":false,"start_date":"2019-09-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099992","publication_url":"https://clinicaltrials.gov/study/NCT04099992","title":"Sympatho-inhibition With Mindfulness in Chronic Kidney Disease (MIND-CKD)","has_exemption":false,"start_date":"2019-09-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04106414","publication_url":"https://clinicaltrials.gov/study/NCT04106414","title":"A Phase II Trial of IDO-Inhibitor, BMS-986205, and PD-1 Inhibitor, Nivolumab, in Patients With Recurrent or Persistent Endometrial Cancer or Endometrial Carcinosarcomas (CA017-056)","has_exemption":false,"start_date":"2019-09-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04130464","publication_url":"https://clinicaltrials.gov/study/NCT04130464","title":"The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial","has_exemption":false,"start_date":"2019-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Ying Liu","sponsor_slug":"ying-liu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04221997","publication_url":"https://clinicaltrials.gov/study/NCT04221997","title":"Extracellular Vesicles as Predictors of Antidepressant Outcomes in Pediatric Anxiety (EV-SOPRANO)","has_exemption":false,"start_date":"2019-11-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115306","publication_url":"https://clinicaltrials.gov/study/NCT04115306","title":"Ph 1/1b/2 Multicenter, Open-Label, FIH Dose Esc & Dose Exp Study to Assess Safety and Tolerability of Orally Administered PMD-026 as a Single Agent and in Combination in Patients With Metastatic or Locally Advanced (Inoperable) RSK2+ Breast Cancer","has_exemption":false,"start_date":"2019-11-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Phoenix Molecular Designs","sponsor_slug":"phoenix-molecular-designs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04238143","publication_url":"https://clinicaltrials.gov/study/NCT04238143","title":"Adipose-Derived Biocellular Regenerative Therapy in Treatment of Osteoarthritis (OA) and Associated Connective Tissue Degeneration and Pain","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Healeon Medical Inc","sponsor_slug":"healeon-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04323735","publication_url":"https://clinicaltrials.gov/study/NCT04323735","title":"Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04088396","publication_url":"https://clinicaltrials.gov/study/NCT04088396","title":"Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.","has_exemption":false,"start_date":"2020-02-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04094610","publication_url":"https://clinicaltrials.gov/study/NCT04094610","title":"A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations","has_exemption":false,"start_date":"2020-03-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Turning Point Therapeutics, Inc.","sponsor_slug":"turning-point-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04253964","publication_url":"https://clinicaltrials.gov/study/NCT04253964","title":"Phase II Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-Small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04167358","publication_url":"https://clinicaltrials.gov/study/NCT04167358","title":"Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis","has_exemption":false,"start_date":"2020-07-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04476953","publication_url":"https://clinicaltrials.gov/study/NCT04476953","title":"COVID-FISETIN: A Phase 2 Placebo-Controlled Pilot Study in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Hospitalized Adults","has_exemption":false,"start_date":"2020-08-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04477629","publication_url":"https://clinicaltrials.gov/study/NCT04477629","title":"Belatacept in De Novo Heart Transplantation - Pilot Study","has_exemption":false,"start_date":"2020-08-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03245541","publication_url":"https://clinicaltrials.gov/study/NCT03245541","title":"A Phase I/II Study of Durvalumab (Medi 4736) and Stereotactic Ablative Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2020-08-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04331275","publication_url":"https://clinicaltrials.gov/study/NCT04331275","title":"Viral Specific T-cells (VSTs) for Treatment of Viral Infections After Solid Organ Transplant","has_exemption":false,"start_date":"2020-08-18","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04508049","publication_url":"https://clinicaltrials.gov/study/NCT04508049","title":"Quantitative Magnetization Transfer MRI for Evaluation of Renal Fibrosis","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04580472","publication_url":"https://clinicaltrials.gov/study/NCT04580472","title":"Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04599036","publication_url":"https://clinicaltrials.gov/study/NCT04599036","title":"Myoelectrolytically Controlled Device in Acute Rehabilitation After Stroke","has_exemption":false,"start_date":"2020-10-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04221815","publication_url":"https://clinicaltrials.gov/study/NCT04221815","title":"IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)","has_exemption":false,"start_date":"2020-10-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04045093","publication_url":"https://clinicaltrials.gov/study/NCT04045093","title":"Rationale and Design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial","has_exemption":false,"start_date":"2020-10-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04412629","publication_url":"https://clinicaltrials.gov/study/NCT04412629","title":"Cabozantinib in High Grade Neuroendocrine Neoplasms","has_exemption":false,"start_date":"2020-11-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04500041","publication_url":"https://clinicaltrials.gov/study/NCT04500041","title":"Casting vs Bracing for Idiopathic Early-Onset Scoliosis","has_exemption":false,"start_date":"2021-02-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04748601","publication_url":"https://clinicaltrials.gov/study/NCT04748601","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age","has_exemption":false,"start_date":"2021-02-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Upsher-Smith Laboratories","sponsor_slug":"upsher-smith-laboratories","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04562870","publication_url":"https://clinicaltrials.gov/study/NCT04562870","title":"A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis","has_exemption":false,"start_date":"2021-03-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04641702","publication_url":"https://clinicaltrials.gov/study/NCT04641702","title":"Comprehensive Assessment of Histopathologic and Physiologic Profile in Esophageal Motility Disorders","has_exemption":false,"start_date":"2021-03-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03826693","publication_url":"https://clinicaltrials.gov/study/NCT03826693","title":"Efficacy of Nitrous Oxide in OCD: Pilot Study","has_exemption":false,"start_date":"2021-04-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04868838","publication_url":"https://clinicaltrials.gov/study/NCT04868838","title":"A Phase 2 Open-label Trial Evaluating the Efficacy and Safety of Daratumumab in Treatment of Patients With Active Lupus Nephritis","has_exemption":false,"start_date":"2021-04-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04046900","publication_url":"https://clinicaltrials.gov/study/NCT04046900","title":"Vaginal Microbiota Transplant to Promote Lactobacillus-dominant Cervicovaginal Communities","has_exemption":false,"start_date":"2021-04-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Douglas Kwon","sponsor_slug":"douglas-kwon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04678154","publication_url":"https://clinicaltrials.gov/study/NCT04678154","title":"Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT - A Multicenter Randomized Control Trial","has_exemption":false,"start_date":"2021-05-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Major Extremity Trauma Research Consortium","sponsor_slug":"major-extremity-trauma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04718168","publication_url":"https://clinicaltrials.gov/study/NCT04718168","title":"GORE® ENFORM Biomaterial Product Study: A Study to Describe Multi-use Biomaterial Performance in Hernia Patients","has_exemption":false,"start_date":"2021-05-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04895241","publication_url":"https://clinicaltrials.gov/study/NCT04895241","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care","has_exemption":false,"start_date":"2021-05-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04855253","publication_url":"https://clinicaltrials.gov/study/NCT04855253","title":"Phase I/II Trial Using E7777 to Enhance Regulatory T-Cell Depletion Prior to CAR-T Therapy for Relapsed/Refractory Large B-Cell Lymphomas","has_exemption":false,"start_date":"2021-06-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05028621","publication_url":"https://clinicaltrials.gov/study/NCT05028621","title":"Exploratory Analysis of the Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease","has_exemption":false,"start_date":"2021-06-18","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04647227","publication_url":"https://clinicaltrials.gov/study/NCT04647227","title":"Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors","has_exemption":false,"start_date":"2021-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"American Thrombosis and Hemostasis Network","sponsor_slug":"american-thrombosis-and-hemostasis-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04892953","publication_url":"https://clinicaltrials.gov/study/NCT04892953","title":"Local Consolidative Therapy (LCT) and Durvalumab (MEDI4736) for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (ENDURE)","has_exemption":false,"start_date":"2021-07-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04575688","publication_url":"https://clinicaltrials.gov/study/NCT04575688","title":"A Randomized Controlled Trial Comparing a Periarticular Injection to a Popliteal Block for Pain Control in Ankle/Hindfoot Osteotomy or Fusion and Ankle Fractures","has_exemption":false,"start_date":"2021-07-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Campbell Clinic","sponsor_slug":"campbell-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04869059","publication_url":"https://clinicaltrials.gov/study/NCT04869059","title":"Treatment of Verbal Retrieval Deficits in Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation","has_exemption":false,"start_date":"2021-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04399941","publication_url":"https://clinicaltrials.gov/study/NCT04399941","title":"Role of Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis","has_exemption":false,"start_date":"2021-08-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05852730","publication_url":"https://clinicaltrials.gov/study/NCT05852730","title":"Optimizing the Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance. Motion Sickness Countermeasures Field Test","has_exemption":false,"start_date":"2021-08-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Repurposed Therapeutics, Inc.","sponsor_slug":"repurposed-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04868604","publication_url":"https://clinicaltrials.gov/study/NCT04868604","title":"A Phase I/IIa Theranostic Study of 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-08-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Clarity Pharmaceuticals Ltd","sponsor_slug":"clarity-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04706923","publication_url":"https://clinicaltrials.gov/study/NCT04706923","title":"A Phase IIa, Open-label, Multiple Ascending Dose Confirmation Study of the Safety and Tolerability of Intravenous Administration of Brincidofovir in Subjects With Adenovirus Infection or Cytomegalovirus Infection","has_exemption":false,"start_date":"2021-08-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"SymBio Pharmaceuticals","sponsor_slug":"symbio-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04679012","publication_url":"https://clinicaltrials.gov/study/NCT04679012","title":"Phase II Study of Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation","has_exemption":false,"start_date":"2021-09-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05059522","publication_url":"https://clinicaltrials.gov/study/NCT05059522","title":"Avelumab Master Protocol: An Open-label Continuation Study for Participants Continuing From Pfizer-sponsored Avelumab Clinical Studies.","has_exemption":false,"start_date":"2021-09-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04835506","publication_url":"https://clinicaltrials.gov/study/NCT04835506","title":"Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04979338","publication_url":"https://clinicaltrials.gov/study/NCT04979338","title":"Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries","has_exemption":false,"start_date":"2021-11-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05069038","publication_url":"https://clinicaltrials.gov/study/NCT05069038","title":"A Phase II Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy for Post and Pre-menopausal Patients With Early Stage Hormone Receptor Positive and Her-2/Neu Negative Breast Cancer","has_exemption":false,"start_date":"2022-03-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05315700","publication_url":"https://clinicaltrials.gov/study/NCT05315700","title":"An Open-Label, Phase 1/2 Study of ORIC-114 as a Single Agent or in Combination With Chemotherapy, in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration","has_exemption":false,"start_date":"2022-03-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"ORIC Pharmaceuticals","sponsor_slug":"oric-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04980222","publication_url":"https://clinicaltrials.gov/study/NCT04980222","title":"A Phase II Study Evaluating the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2022-03-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444751","publication_url":"https://clinicaltrials.gov/study/NCT05444751","title":"Evaluating General Anesthesia With Erector Spinae Plane Block vs. Spinal Anesthesia With Erector Spinae Plane Block in Lumbar Decompression Surgeries","has_exemption":false,"start_date":"2022-03-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05101746","publication_url":"https://clinicaltrials.gov/study/NCT05101746","title":"Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Effects on End Organ Damage to the Brain and Kidney","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04481919","publication_url":"https://clinicaltrials.gov/study/NCT04481919","title":"A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients With Acute Heart Failure","has_exemption":false,"start_date":"2022-05-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727942","publication_url":"https://clinicaltrials.gov/study/NCT06727942","title":"Toward Healthy Living: Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes","has_exemption":false,"start_date":"2022-05-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05186974","publication_url":"https://clinicaltrials.gov/study/NCT05186974","title":"An Open-label, Multicenter, Phase 2 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Without Actionable Genomic Alterations","has_exemption":false,"start_date":"2022-05-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05320198","publication_url":"https://clinicaltrials.gov/study/NCT05320198","title":"RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia","has_exemption":false,"start_date":"2022-06-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Disc Medicine, Inc","sponsor_slug":"disc-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05020028","publication_url":"https://clinicaltrials.gov/study/NCT05020028","title":"The Use of Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis. A Double-Blind, Randomized Control Study","has_exemption":false,"start_date":"2022-06-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05113368","publication_url":"https://clinicaltrials.gov/study/NCT05113368","title":"Efficacy of Oral Regorafenib Combined With Intra-muscular Injection of Fulvestrant in Patients With Recurrent Low-grade Serous Ovarian Cancer: A Phase II Single Arm Trial","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Sarah K. Lynam MD","sponsor_slug":"sarah-k-lynam-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318105","publication_url":"https://clinicaltrials.gov/study/NCT05318105","title":"A Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Aquadex System in Patients With Heart Failure and Fluid Overload","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Nuwellis, Inc.","sponsor_slug":"nuwellis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05303064","publication_url":"https://clinicaltrials.gov/study/NCT05303064","title":"A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)","has_exemption":false,"start_date":"2022-06-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04066348","publication_url":"https://clinicaltrials.gov/study/NCT04066348","title":"Clinical Trial of Etanercept (TNF-α Blocker) for Treatment of Blast-Induced Tinnitus","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05308446","publication_url":"https://clinicaltrials.gov/study/NCT05308446","title":"Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer","has_exemption":false,"start_date":"2022-07-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05322850","publication_url":"https://clinicaltrials.gov/study/NCT05322850","title":"Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) Recipients With Hematologic Malignancies (HM)","has_exemption":false,"start_date":"2022-08-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05149573","publication_url":"https://clinicaltrials.gov/study/NCT05149573","title":"Investigation of Non-Invasive Pulsed Electromagnetic Field (PEMF) Therapy for Female Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)","has_exemption":false,"start_date":"2022-08-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05534321","publication_url":"https://clinicaltrials.gov/study/NCT05534321","title":"Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease (PROMISSeD Trial)","has_exemption":false,"start_date":"2022-08-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05566574","publication_url":"https://clinicaltrials.gov/study/NCT05566574","title":"RP-3500 (ATRi) + External Beam Radiotherapy (EBRT) for the Palliative Treatment of Metastatic Disease","has_exemption":false,"start_date":"2022-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254314","publication_url":"https://clinicaltrials.gov/study/NCT05254314","title":"Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-related, Symptomatic Asthma (GATA-3)","has_exemption":false,"start_date":"2022-10-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05451771","publication_url":"https://clinicaltrials.gov/study/NCT05451771","title":"An Open-label Phase I/II Trial of Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Systemic Light-Chain Amyloidosis","has_exemption":false,"start_date":"2022-10-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rajshekhar Chakraborty, MD","sponsor_slug":"rajshekhar-chakraborty-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519683","publication_url":"https://clinicaltrials.gov/study/NCT05519683","title":"Effects of Home-based TEA for Abdominal Pain in Patients With Irritable Bowel Syndrome (IBS)","has_exemption":false,"start_date":"2022-11-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05291091","publication_url":"https://clinicaltrials.gov/study/NCT05291091","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of EDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy","has_exemption":false,"start_date":"2022-11-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Edgewise Therapeutics, Inc.","sponsor_slug":"edgewise-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407324","publication_url":"https://clinicaltrials.gov/study/NCT05407324","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients With Amyotrophic Lateral Sclerosis (DAZALS)","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03953144","publication_url":"https://clinicaltrials.gov/study/NCT03953144","title":"Synapse 3D With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial: A Phase I Safety and Feasibility Trial","has_exemption":false,"start_date":"2022-12-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Healthcare Hamilton","sponsor_slug":"st-josephs-healthcare-hamilton","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669950","publication_url":"https://clinicaltrials.gov/study/NCT05669950","title":"A Multi-site, Open-label, Sequential-group, Multiple-dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia","has_exemption":false,"start_date":"2022-12-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05592002","publication_url":"https://clinicaltrials.gov/study/NCT05592002","title":"A Multicenter Study to Assess the Safety and Effectiveness of the Genio® Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Subjects With Complete Concentric Collapse of the Soft Palate.","has_exemption":false,"start_date":"2022-12-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Nyxoah S.A.","sponsor_slug":"nyxoah-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05499013","publication_url":"https://clinicaltrials.gov/study/NCT05499013","title":"Phase 1/2 Study With an Open-label Dose Escalation Phase Followed by a Randomized, Double-blind Phase of SLN124 in Patients With Polycythemia Vera","has_exemption":false,"start_date":"2023-01-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Silence Therapeutics plc","sponsor_slug":"silence-therapeutics-plc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05536804","publication_url":"https://clinicaltrials.gov/study/NCT05536804","title":"Tirzepatide Study of Renal Function in People With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease Using Multiparametric Magnetic Resonance Imaging","has_exemption":false,"start_date":"2023-02-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06078878","publication_url":"https://clinicaltrials.gov/study/NCT06078878","title":"Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter","has_exemption":false,"start_date":"2023-02-13","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gentuity, LLC","sponsor_slug":"gentuity-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05462145","publication_url":"https://clinicaltrials.gov/study/NCT05462145","title":"A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2023-03-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Kardium Inc.","sponsor_slug":"kardium-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766254","publication_url":"https://clinicaltrials.gov/study/NCT05766254","title":"Identify the Optimal TMS Target to Modulate Midcingulate Reward Activity in Smokers","has_exemption":false,"start_date":"2023-03-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05835999","publication_url":"https://clinicaltrials.gov/study/NCT05835999","title":"Clinical Evaluation of mTORC1 Inhibition for Geroprotection","has_exemption":false,"start_date":"2023-03-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05346809","publication_url":"https://clinicaltrials.gov/study/NCT05346809","title":"Randomized Phase 2 Trial of Isatuximab During Autologous Stem Cell Collection and Transplantation Period in Patients With Multiple Myeloma, Relapsed Hodgkin's and Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2023-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Divaya Bhutani","sponsor_slug":"divaya-bhutani","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838729","publication_url":"https://clinicaltrials.gov/study/NCT05838729","title":"Phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or Metastatic Head-Neck Cancer","has_exemption":false,"start_date":"2023-04-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Coordination Pharmaceuticals, Inc.","sponsor_slug":"coordination-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672901","publication_url":"https://clinicaltrials.gov/study/NCT05672901","title":"Comparison of a Novel Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause: a Non-inferiority Trial","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stratpharma AG","sponsor_slug":"stratpharma-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05801978","publication_url":"https://clinicaltrials.gov/study/NCT05801978","title":"Systems Biological Assessment of the Durability of Vaccine Responses","has_exemption":false,"start_date":"2023-04-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05850689","publication_url":"https://clinicaltrials.gov/study/NCT05850689","title":"A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder","has_exemption":false,"start_date":"2023-05-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514106","publication_url":"https://clinicaltrials.gov/study/NCT05514106","title":"Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease","has_exemption":false,"start_date":"2023-05-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05740176","publication_url":"https://clinicaltrials.gov/study/NCT05740176","title":"A Multi-Center, Prospective, Historically Controlled Pivotal Trial Comparing the Safety and Effectiveness of the Synergy Disc to Anterior Cervical Discectomy and Fusion in Patients With Two-Level Symptomatic Cervical Degenerative Disc Disease (DDD)","has_exemption":false,"start_date":"2023-06-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Synergy Spine Solutions","sponsor_slug":"synergy-spine-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05888831","publication_url":"https://clinicaltrials.gov/study/NCT05888831","title":"A Phase 1/2 Study of BMS-986449 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-06-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05857930","publication_url":"https://clinicaltrials.gov/study/NCT05857930","title":"A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo Given in Children Aged 6 Months to 5 Years With Recurrent Wheezing","has_exemption":false,"start_date":"2023-06-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"OM Pharma SA","sponsor_slug":"om-pharma-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05881460","publication_url":"https://clinicaltrials.gov/study/NCT05881460","title":"Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease","has_exemption":false,"start_date":"2023-07-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Synergic Medical Technologies, Inc.","sponsor_slug":"synergic-medical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05394831","publication_url":"https://clinicaltrials.gov/study/NCT05394831","title":"A Phase 1/2, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of JIN-A02 in Patients With EGFR Mutant Advanced Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2023-07-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"J Ints Bio","sponsor_slug":"j-ints-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05843578","publication_url":"https://clinicaltrials.gov/study/NCT05843578","title":"A Phase 2a, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AGMB-129 in Patients With Fibrostenotic Crohn's Disease","has_exemption":false,"start_date":"2023-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Agomab Spain S.L.U.","sponsor_slug":"agomab-spain-slu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938543","publication_url":"https://clinicaltrials.gov/study/NCT05938543","title":"Noninvasive Neuromodulation of a Novel Cerebellar Satiety Circuit in Prader-Willi Syndrome","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214026","publication_url":"https://clinicaltrials.gov/study/NCT06214026","title":"The Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis for People With Above-Knee Amputations, Bilateral Amputations, or Limited Mobility","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972564","publication_url":"https://clinicaltrials.gov/study/NCT05972564","title":"The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function","has_exemption":false,"start_date":"2023-09-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028828","publication_url":"https://clinicaltrials.gov/study/NCT06028828","title":"Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)","has_exemption":false,"start_date":"2023-09-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05986851","publication_url":"https://clinicaltrials.gov/study/NCT05986851","title":"A Phase II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients With MGMT Unmethylated Glioblastoma","has_exemption":false,"start_date":"2023-09-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Cantex Pharmaceuticals","sponsor_slug":"cantex-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05842044","publication_url":"https://clinicaltrials.gov/study/NCT05842044","title":"NSAID Use After Robotic Partial Nephrectomy (No-PAIN): a Randomized, Controlled Trial","has_exemption":false,"start_date":"2023-09-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05812924","publication_url":"https://clinicaltrials.gov/study/NCT05812924","title":"A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause","has_exemption":false,"start_date":"2023-09-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05824728","publication_url":"https://clinicaltrials.gov/study/NCT05824728","title":"Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis","has_exemption":false,"start_date":"2023-09-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975359","publication_url":"https://clinicaltrials.gov/study/NCT05975359","title":"A Pilot Study of the Interi Manifold With Traditional Surgical Drains in Implant-Based Breast Reconstruction","has_exemption":false,"start_date":"2023-10-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05362929","publication_url":"https://clinicaltrials.gov/study/NCT05362929","title":"Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color","has_exemption":false,"start_date":"2023-10-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05997030","publication_url":"https://clinicaltrials.gov/study/NCT05997030","title":"Early Feasibility Study of Low-Intensity Focused Ultrasound (LIFU) Neuromodulation in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Ali Rezai","sponsor_slug":"ali-rezai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06138782","publication_url":"https://clinicaltrials.gov/study/NCT06138782","title":"Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06079190","publication_url":"https://clinicaltrials.gov/study/NCT06079190","title":"A Phase 2, Parallel Group, Randomized, Double- Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared With Placebo in Patients With Early Alzheimer's Disease","has_exemption":false,"start_date":"2023-10-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06108219","publication_url":"https://clinicaltrials.gov/study/NCT06108219","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)","has_exemption":false,"start_date":"2023-10-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05914064","publication_url":"https://clinicaltrials.gov/study/NCT05914064","title":"Gravitas Feeding Tube System Placement Validation in Neonates","has_exemption":false,"start_date":"2023-10-27","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gravitas Medical, Inc.","sponsor_slug":"gravitas-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05604560","publication_url":"https://clinicaltrials.gov/study/NCT05604560","title":"A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer","has_exemption":false,"start_date":"2023-11-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Lei Zheng","sponsor_slug":"lei-zheng","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06132256","publication_url":"https://clinicaltrials.gov/study/NCT06132256","title":"A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2023-12-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Syndax Pharmaceuticals","sponsor_slug":"syndax-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06026371","publication_url":"https://clinicaltrials.gov/study/NCT06026371","title":"Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2023-12-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028074","publication_url":"https://clinicaltrials.gov/study/NCT06028074","title":"A First-in-Human, Open-Label, Phase 1/2 Dose-Escalation With Enrichment and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GIM-122 as a Single Agent in Adult Subjects With Advanced Solid Malignancies","has_exemption":false,"start_date":"2023-12-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Georgiamune Inc","sponsor_slug":"georgiamune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06278844","publication_url":"https://clinicaltrials.gov/study/NCT06278844","title":"Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication","has_exemption":false,"start_date":"2023-12-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Antwerp","sponsor_slug":"university-hospital-antwerp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06056830","publication_url":"https://clinicaltrials.gov/study/NCT06056830","title":"Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Clarity Pharmaceuticals Ltd","sponsor_slug":"clarity-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05758896","publication_url":"https://clinicaltrials.gov/study/NCT05758896","title":"Effect on Contrast Induced Acute Kidney Injury of APX-115 in Subjects Undergoing Percutaneous Coronary Intervention A Randomized, Double-blind, Parallel Group, Multicenter, Multi-national Trial","has_exemption":false,"start_date":"2023-12-27","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Aptabio Therapeutics, Inc.","sponsor_slug":"aptabio-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06043414","publication_url":"https://clinicaltrials.gov/study/NCT06043414","title":"Incisional Surgical Site Infection and Fascial Dehiscence After Abdominal Fascial Closure With Triclosan-Coated Barbed Suture vs Polydioxanone Suture After Emergency Exploratory Laparotomy: A Randomized Control Trial","has_exemption":false,"start_date":"2024-01-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06027268","publication_url":"https://clinicaltrials.gov/study/NCT06027268","title":"ToPCourT: A Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2024-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05719714","publication_url":"https://clinicaltrials.gov/study/NCT05719714","title":"Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease","has_exemption":false,"start_date":"2024-01-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06074510","publication_url":"https://clinicaltrials.gov/study/NCT06074510","title":"A Phase 4 Open-Label Multicenter Study of PYLARIFY® PET/CT or PET/MRI in Men With Newly Diagnosed Favorable Intermediate Risk (FIR) Prostate Cancer","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Lantheus Medical Imaging","sponsor_slug":"lantheus-medical-imaging","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06007976","publication_url":"https://clinicaltrials.gov/study/NCT06007976","title":"Impact of Variable Treatment Frequencies of Low-Level Laser in Reduce Low-Back Pain","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088979","publication_url":"https://clinicaltrials.gov/study/NCT06088979","title":"A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye Disease","has_exemption":false,"start_date":"2024-02-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Tourmaline Bio, Inc.","sponsor_slug":"tourmaline-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06344481","publication_url":"https://clinicaltrials.gov/study/NCT06344481","title":"A Prospective, Multicenter, Single-Arm, 2-Phase First-in-Human Feasibility Study of the HYALEX® Cartilage System","has_exemption":false,"start_date":"2024-03-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Hyalex Orthopaedics, Inc.","sponsor_slug":"hyalex-orthopaedics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04597437","publication_url":"https://clinicaltrials.gov/study/NCT04597437","title":"Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254950","publication_url":"https://clinicaltrials.gov/study/NCT06254950","title":"A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Induction Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2024-03-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06235151","publication_url":"https://clinicaltrials.gov/study/NCT06235151","title":"Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Curium US LLC","sponsor_slug":"curium-us-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06073132","publication_url":"https://clinicaltrials.gov/study/NCT06073132","title":"An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) [EBShield Study]","has_exemption":false,"start_date":"2024-04-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"TWi Biotechnology, Inc.","sponsor_slug":"twi-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06344052","publication_url":"https://clinicaltrials.gov/study/NCT06344052","title":"A Phase 2 Study to Assess the Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma","has_exemption":false,"start_date":"2024-04-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stamford Pharmaceuticals, Inc.","sponsor_slug":"stamford-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849389","publication_url":"https://clinicaltrials.gov/study/NCT05849389","title":"Vosoritide for Treatment of Short Stature in Girls With Turner Syndrome","has_exemption":false,"start_date":"2024-04-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Roopa Kanakatti Shankar, MBBS, MS","sponsor_slug":"roopa-kanakatti-shankar-mbbs-ms","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05998863","publication_url":"https://clinicaltrials.gov/study/NCT05998863","title":"Effervescent Calcium Magnesium Citrate to Prevent Mineral Metabolism and Renal Complications of Chronic Proton Pump Inhibitor Therapy","has_exemption":false,"start_date":"2024-04-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851886","publication_url":"https://clinicaltrials.gov/study/NCT04851886","title":"PostureCheck: A Vision-based Compensatory-posture-detection Tool to Enhance Performance of the BURT Upper-extremity Stroke-therapy","has_exemption":false,"start_date":"2024-04-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06339008","publication_url":"https://clinicaltrials.gov/study/NCT06339008","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis","has_exemption":false,"start_date":"2024-04-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06230354","publication_url":"https://clinicaltrials.gov/study/NCT06230354","title":"A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis","has_exemption":false,"start_date":"2024-05-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06689111","publication_url":"https://clinicaltrials.gov/study/NCT06689111","title":"Investigation of Whether the Presence of the Typical LBBB- Mechanical Stimulation Pattern - Documented Through 2DSE (Two-dimensional Strain Echocardiography) - is Associated With Increased Rates of Acute Improvement in Global Myocardial Work Efficiency (GWE) Compared to the Absence of This Activation Pattern, in Patients in Need of Device Implantation for Cardiac Resynchronization Therapy in Whom LBBp is Chosen Compared to the Classic Biventricular Pacing Method","has_exemption":false,"start_date":"2024-05-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University Hospital of Patras","sponsor_slug":"university-hospital-of-patras","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06300996","publication_url":"https://clinicaltrials.gov/study/NCT06300996","title":"Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb Protocol","has_exemption":false,"start_date":"2024-05-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Marco Capogrosso","sponsor_slug":"marco-capogrosso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05422690","publication_url":"https://clinicaltrials.gov/study/NCT05422690","title":"A Phase II Single-center, Open-label, Single Arm Study of Induction Gemcitabine, Cisplatin and Durvalumab Followed by Gemcitabine, Cisplatin and Yttrium-90 (Y-90) Radioembolization for the Treatment of Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2024-06-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06334133","publication_url":"https://clinicaltrials.gov/study/NCT06334133","title":"Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes: A 26-Week Double-Blind, Randomized, Placebo-Controlled Phase 3 Study","has_exemption":false,"start_date":"2024-06-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"vTv Therapeutics","sponsor_slug":"vtv-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03984565","publication_url":"https://clinicaltrials.gov/study/NCT03984565","title":"PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product","has_exemption":false,"start_date":"2024-06-27","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Staci Gruber, Ph.D.","sponsor_slug":"staci-gruber-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06392386","publication_url":"https://clinicaltrials.gov/study/NCT06392386","title":"An Open-label, Uncontrolled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Efgartigimod PH20 SC in Participants From 2 to Less Than 18 Years of Age With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-06-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06498479","publication_url":"https://clinicaltrials.gov/study/NCT06498479","title":"ARTEMIS-008：A Multicenter, Randomized, Open-label, Phase 3 Study of HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy","has_exemption":false,"start_date":"2024-07-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Hansoh BioMedical R&D Company","sponsor_slug":"hansoh-biomedical-rd-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100744","publication_url":"https://clinicaltrials.gov/study/NCT06100744","title":"Open-label, Randomized, Assessor-blinded, Efficacy, Safety, Tolerability, and Pharmacokinetics Study of Subcutaneous Risankizumab With an Adalimumab Reference Arm in Children With Active Juvenile Psoriatic Arthritis","has_exemption":false,"start_date":"2024-07-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06519097","publication_url":"https://clinicaltrials.gov/study/NCT06519097","title":"A Randomized, Placebo-Controlled Trial of Tocotrienol in the Prevention of Pancreatic Intraductal Papillary Mucinous Neoplasm Progression","has_exemption":false,"start_date":"2024-07-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06405633","publication_url":"https://clinicaltrials.gov/study/NCT06405633","title":"A Phase 1b/2a Open-label Single Ascending Doses (SAD) and Multiple Ascending Doses (MAD) Research Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Participants With AATD Pi*ZZ on WVE-006 (RestorAATion-2)","has_exemption":false,"start_date":"2024-07-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wave Life Sciences Ltd.","sponsor_slug":"wave-life-sciences-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06362252","publication_url":"https://clinicaltrials.gov/study/NCT06362252","title":"A Phase 1b/2, Multicenter, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody-Drug Conjugate (ADC), in Combination With Atezolizumab With or Without Carboplatin as First-line Induction or Maintenance, in Subjects With Extensive-stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung03)","has_exemption":false,"start_date":"2024-07-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169215","publication_url":"https://clinicaltrials.gov/study/NCT06169215","title":"A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2024-07-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100276","publication_url":"https://clinicaltrials.gov/study/NCT06100276","title":"A Phase 1/2, Multicenter, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS).","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"UniQure Biopharma B.V.","sponsor_slug":"uniqure-biopharma-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06534892","publication_url":"https://clinicaltrials.gov/study/NCT06534892","title":"A Phase 3b, Randomized, Open Label, Multicountry, Multi-center, Extension and Crossover Vaccination Study to Evaluate the Immunogenicity and Safety of Different Revaccination Schedules and Persistence of a Single Dose of the RSVPreF3 OA Vaccine in Adults Aged 60 Years and Above Who Participated in the RSV OA=ADJ-006 Study","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06571045","publication_url":"https://clinicaltrials.gov/study/NCT06571045","title":"A Randomized, Double-Masked, Multi-Center, 3-Arm Pivotal Phase 2/3 Study to Evaluate The Efficacy and Safety of Intravitreal EYE103 Compared With Intravitreal Ranibizumab (0.5mg) in Participants With Diabetic Macular Edema","has_exemption":false,"start_date":"2024-08-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"EyeBiotech Ltd.","sponsor_slug":"eyebiotech-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06407232","publication_url":"https://clinicaltrials.gov/study/NCT06407232","title":"An Interventional Study of Letermovir for Secondary Prophylaxis After Treatment of Cytomegalovirus Infection in High Risk (D+/R-) Kidney and Kidney/Pancreas Transplant Recipients","has_exemption":false,"start_date":"2024-08-08","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05334485","publication_url":"https://clinicaltrials.gov/study/NCT05334485","title":"Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery (PESTI Trial)","has_exemption":false,"start_date":"2024-09-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stefan Holubar MD MS FACS, FASCRS","sponsor_slug":"stefan-holubar-md-ms-facs-fascrs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06366724","publication_url":"https://clinicaltrials.gov/study/NCT06366724","title":"LIFT: Life Improvement Trial","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06597292","publication_url":"https://clinicaltrials.gov/study/NCT06597292","title":"Vision Improvement for Patients With Presbyopia","has_exemption":false,"start_date":"2024-09-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"VIS, Inc.","sponsor_slug":"vis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06341868","publication_url":"https://clinicaltrials.gov/study/NCT06341868","title":"Dynamic Gait-Synchronous Neuromuscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction","has_exemption":false,"start_date":"2024-09-19","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Keller Army Community Hospital","sponsor_slug":"keller-army-community-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449677","publication_url":"https://clinicaltrials.gov/study/NCT06449677","title":"A Randomized Trial of the Insulin-only Bionic Pancreas in Cystic Fibrosis Related Diabetes","has_exemption":false,"start_date":"2024-09-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287969","publication_url":"https://clinicaltrials.gov/study/NCT07287969","title":"Prospective Randomized Trial to Determine the Safety of Reusing Walking Boot Components for Patients Recovering From Acute Foot and Ankle Injuries","has_exemption":false,"start_date":"2024-09-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06293300","publication_url":"https://clinicaltrials.gov/study/NCT06293300","title":"Understanding and Treating TBI Associated Photophobia With Botulinum Toxin Type A and Its Impact on Visual Function","has_exemption":false,"start_date":"2024-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06437548","publication_url":"https://clinicaltrials.gov/study/NCT06437548","title":"Spinal Cord Stimulation for Reanimation After Nervous System Injury","has_exemption":false,"start_date":"2024-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439953","publication_url":"https://clinicaltrials.gov/study/NCT06439953","title":"Impact of Prophylactic Use of Irrisept Irrigation System for Spinal Instrumentation","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06618963","publication_url":"https://clinicaltrials.gov/study/NCT06618963","title":"Effect of Omalizumab in the Skin of Food Allergy Patients","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"National Jewish Health","sponsor_slug":"national-jewish-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593210","publication_url":"https://clinicaltrials.gov/study/NCT06593210","title":"Safety and Immunogenicity of Non-live, Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine in Allogeneic Stem Cell Transplant and Lung Transplant Recipients","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University Health Network, Toronto","sponsor_slug":"university-health-network-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568692","publication_url":"https://clinicaltrials.gov/study/NCT06568692","title":"A Phase 2, Open-Label Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-10-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Processa Pharmaceuticals","sponsor_slug":"processa-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06417814","publication_url":"https://clinicaltrials.gov/study/NCT06417814","title":"A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants With EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Has Progressed on Prior Osimertinib Treatment (TROPION-Lung15)","has_exemption":false,"start_date":"2024-10-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06582680","publication_url":"https://clinicaltrials.gov/study/NCT06582680","title":"Aging, Beta Blockers, and Thermoregulatory Responses","has_exemption":false,"start_date":"2024-10-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616831","publication_url":"https://clinicaltrials.gov/study/NCT06616831","title":"Development of At-Home Transcutaneous Auricular Vagus Nerve Stimulation for Post-Stroke Rehabilitation","has_exemption":false,"start_date":"2024-10-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06888063","publication_url":"https://clinicaltrials.gov/study/NCT06888063","title":"Preventing Liver Recurrence After Partial Hepatectomy for Intrahepatic Cholangiocarcinoma Using Adjuvant Hepatic Arterial Infusion Pump Chemotherapy - PUMP IV Trial","has_exemption":false,"start_date":"2024-11-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Erasmus Medical Center","sponsor_slug":"erasmus-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06648759","publication_url":"https://clinicaltrials.gov/study/NCT06648759","title":"The Role of a Vagal Stimulator to Reduce the Frequency and Duration on Nasogastric Tube Following Abdominal Surgery","has_exemption":false,"start_date":"2024-12-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Jacques E. Chelly","sponsor_slug":"jacques-e-chelly","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06273072","publication_url":"https://clinicaltrials.gov/study/NCT06273072","title":"Metformin IN Asthma for Overweight and Obese Individuals (MINA)","has_exemption":false,"start_date":"2024-12-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06547151","publication_url":"https://clinicaltrials.gov/study/NCT06547151","title":"A Phase 2, Prospective, Multinational, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of AMOR-1 as a Treatment of Hypocalcemia Associated With Hypoparathyroidism by Replacement of Currently Used Calcium Supplements (CS) in Adults.","has_exemption":false,"start_date":"2024-12-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Amorphical Ltd.","sponsor_slug":"amorphical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05426967","publication_url":"https://clinicaltrials.gov/study/NCT05426967","title":"ADEPT: Adaptive Trial for the Treatment of Depressive Symptoms Associated With Concussion Using Repetitive Transcranial Magnetic Stimulation Protocols","has_exemption":false,"start_date":"2024-12-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742190","publication_url":"https://clinicaltrials.gov/study/NCT06742190","title":"A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Empasiprubart Versus Intravenous Immunoglobulin in Adults With Multifocal Motor Neuropathy","has_exemption":false,"start_date":"2024-12-18","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06705387","publication_url":"https://clinicaltrials.gov/study/NCT06705387","title":"DeTECTS: Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE","has_exemption":false,"start_date":"2024-12-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05488457","publication_url":"https://clinicaltrials.gov/study/NCT05488457","title":"Pharmacokinetics and Pharmacodynamics of Oxytocin in Cesarean Delivery","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06860867","publication_url":"https://clinicaltrials.gov/study/NCT06860867","title":"A Multi-center Traditional Feasibility Trial of the PerQdisc Artificial Implant in Treatment of Single-level Discogenic Back Pain.","has_exemption":false,"start_date":"2025-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Spinal Stabilization Technologies","sponsor_slug":"spinal-stabilization-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06033703","publication_url":"https://clinicaltrials.gov/study/NCT06033703","title":"Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Primary Rhegmatogenous Detachments and Retinal Detachment Due to Proliferative Vitreoretinopathy or Open-Globe Injury: A Phase I/II Clinical Trial","has_exemption":false,"start_date":"2025-01-14","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06680830","publication_url":"https://clinicaltrials.gov/study/NCT06680830","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Extension to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease (NEULARK)","has_exemption":false,"start_date":"2025-01-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Neuron23 Inc.","sponsor_slug":"neuron23-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06523439","publication_url":"https://clinicaltrials.gov/study/NCT06523439","title":"Investigating a Truncated Version of SAINT in Treatment-Naive Adolescents With Depression: An Open-Label Acceptability Trial","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06717009","publication_url":"https://clinicaltrials.gov/study/NCT06717009","title":"A Prospective, Multicenter, Randomized Controlled Study of Three-dimensional Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","sponsor_slug":"tianjin-medical-university-cancer-institute-and-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06830629","publication_url":"https://clinicaltrials.gov/study/NCT06830629","title":"An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults With Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype","has_exemption":false,"start_date":"2025-02-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Maze Therapeutics","sponsor_slug":"maze-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06793371","publication_url":"https://clinicaltrials.gov/study/NCT06793371","title":"A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-4021586 in Adults With Symptomatic Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2025-02-06","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Cytokinetics","sponsor_slug":"cytokinetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824402","publication_url":"https://clinicaltrials.gov/study/NCT06824402","title":"A Prospective, Randomized Clinical Trial to Evaluate the Feasibility of Miniature Cryoprobe Biopsy to Detect Acute and Chronic Lung Transplant Rejection in Lung Transplant Recipients","has_exemption":false,"start_date":"2025-02-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05457972","publication_url":"https://clinicaltrials.gov/study/NCT05457972","title":"Postpartum Vaginal Estrogen for Sexual Function in Breastfeeding Patients: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-02-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06860386","publication_url":"https://clinicaltrials.gov/study/NCT06860386","title":"A Phase II Study Assessing the Feasibility and Clinical Efficacy of Adaptive Immunotherapy Combination With VEGFR-TKI in Patients With Advanced Renal Cell Carcinoma","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06505187","publication_url":"https://clinicaltrials.gov/study/NCT06505187","title":"Celecoxib Pain Management Following Superficial Parotidectomy: Opioid Sparing Protocol","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06656533","publication_url":"https://clinicaltrials.gov/study/NCT06656533","title":"Improving Insomnia Treatment by Optimizing Timing of rTMS Administration","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06836739","publication_url":"https://clinicaltrials.gov/study/NCT06836739","title":"At-Home Feasibility Trial of Genital Nerve Stimulation to Modulate Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"MetroHealth Medical Center","sponsor_slug":"metrohealth-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06514001","publication_url":"https://clinicaltrials.gov/study/NCT06514001","title":"A Phase 2, Open Label, Study of AMDX-2011P as a Retinal Tracer in Participants With Alzheimer's Disease","has_exemption":false,"start_date":"2025-03-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Amydis Inc.","sponsor_slug":"amydis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636786","publication_url":"https://clinicaltrials.gov/study/NCT06636786","title":"Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) - (Optimizing Acute Stress Reaction Interventions With TNX-102 SL - OASIS)","has_exemption":false,"start_date":"2025-03-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05251636","publication_url":"https://clinicaltrials.gov/study/NCT05251636","title":"A Double-Masked, Multi-center, Active Controlled Safety and Efficacy Study of Adjunct Episcleral Brachytherapy for Polypoid Choroidal Vasculopathy","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Salutaris Medical Devices, Inc.","sponsor_slug":"salutaris-medical-devices-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06803667","publication_url":"https://clinicaltrials.gov/study/NCT06803667","title":"Use of the Moving Shot Radiofrequency Ablation Technique for the Treatment of Vascular Anomalies","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06865885","publication_url":"https://clinicaltrials.gov/study/NCT06865885","title":"Study of Optimal LDL-C Value Enhancement With Inclisiran in Patients With Multiple Comorbidities in Which There Are Drug-Drug Interactions Limiting LDL-C Lowering","has_exemption":false,"start_date":"2025-04-03","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06910358","publication_url":"https://clinicaltrials.gov/study/NCT06910358","title":"APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)","has_exemption":false,"start_date":"2025-04-04","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Disc Medicine, Inc","sponsor_slug":"disc-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06868264","publication_url":"https://clinicaltrials.gov/study/NCT06868264","title":"Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects With Chronic Hepatitis C Virus (HCV) Infection","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Atea Pharmaceuticals, Inc.","sponsor_slug":"atea-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06941441","publication_url":"https://clinicaltrials.gov/study/NCT06941441","title":"Remotely-Monitored Exercise to Enhance Functional Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Initiating Sotatercept Therapy: A Single-site Feasibility Study","has_exemption":false,"start_date":"2025-04-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06495138","publication_url":"https://clinicaltrials.gov/study/NCT06495138","title":"Daily Versus Intermittent Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis","has_exemption":false,"start_date":"2025-04-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847165","publication_url":"https://clinicaltrials.gov/study/NCT06847165","title":"Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure","has_exemption":false,"start_date":"2025-04-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07065773","publication_url":"https://clinicaltrials.gov/study/NCT07065773","title":"An Open Label Study to Investigate the Safety and Tolerability of Trichostatin A in Patients With Mild to Severe Onychomycosis","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982183","publication_url":"https://clinicaltrials.gov/study/NCT06982183","title":"The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes: A Randomized, Blinded, Placebo Controlled Study","has_exemption":false,"start_date":"2025-05-27","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Walter Reed Army Institute of Research (WRAIR)","sponsor_slug":"walter-reed-army-institute-of-research-wrair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526208","publication_url":"https://clinicaltrials.gov/study/NCT06526208","title":"Phase 2 Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of an Oral Marijuana-Based Investigational Medical Product to Treat Anxiety in Adults With Autism Spectrum Disorder (ASD)","has_exemption":false,"start_date":"2025-05-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Southwest Autism Research & Resource Center","sponsor_slug":"southwest-autism-research-resource-center","status":"ongoing","is_pact":false,"days_late":null}]}